Toll-Like Receptor 4 in Ventilator-Induced Lung Injuries
Journal of Cellular & Molecular Anesthesia,
Vol. 1 No. 1 (2016),
21 Azar 2015
,
Page 34-39
https://doi.org/10.22037/jcma.v1i1.10579
Abstract
Toll like receptors (TLRs) recognize pathogens and generate an immediate defense response by inducing the production of pro-inflammatory cytokines, which rapidly destroy or limit the pathogens. In their bridging role, TLR downstream signals link innate and adaptive immunity, particularly by mediating DC maturation and activation of pathogen specific T lymphocytes. These pathways lead to the activation of professional APCs, which is followed by enhanced expression of surface molecules, MHC and co-stimulatory molecules [CD40, CD80, CD86 and CD70].TLRs are expressed in a variety of cell types, mostly within the immune system where they have been linked to different cellular activation states, immune defense, maintenance of homeostasis, and various diseases. TLRs and related immunological pathways are being extensively studied for research, diagnostic and therapeutic purposes. Most mammalian species have between ten and fifteen types of TLRs. Ten functional TLRs (TLR1-10) have been identified in human.
- toll-like receptor 4
- ventilator
- lung injuries
How to Cite
References
O'Neill LA. TLRs: Professor Mechnikov, sit on your hat. Trends in immunology. 2004 Dec;25(12):687-93. PubMed PMID: 15530840. Epub 2004/11/09. eng.
O'Neill LA. Immunity's early-warning system. Scientific American. 2005 Jan;292(1):24-31. PubMed PMID: 15724335. Epub 2005/02/24. eng.
Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nature reviews Immunology. 2005 Jun;5(6):446-58. PubMed PMID: 15928677. Epub 2005/06/02. eng.
Takeda K, Akira S. Toll-like receptors in innate immunity. International immunology. 2005 Jan;17(1):1-14. PubMed PMID: 15585605. Epub 2004/12/09. eng.
Takeda K, Akira S. Roles of Toll-like receptors in innate immune responses. Genes to cells : devoted to molecular & cellular mechanisms. 2001 Sep;6(9):733-42. PubMed PMID: 11554921. Epub 2001/09/14. eng.
Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. Journal of leukocyte biology. 2004 Sep;76(3):514-9. PubMed PMID: 15178705. Epub 2004/06/05. eng.
Medzhitov R. Toll-like receptors and innate immunity. Nature reviews Immunology. 2001 Nov;1(2):135-45. PubMed PMID: 11905821. Epub 2002/03/22. eng.
Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature immunology. 2001 Aug;2(8):675-80. PubMed PMID: 11477402. Epub 2001/07/31. eng.
Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. Journal of immunology (Baltimore, Md : 1950). 2000 Jan 15;164(2):558-61. PubMed PMID: 10623794. Epub 2000/01/07. eng.
Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN, Witztum JL. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. The Journal of biological chemistry. 2003 Jan 17;278(3):1561-8. PubMed PMID: 12424240. Epub 2002/11/09. eng.
Methe H, Brunner S, Wiegand D, Nabauer M, Koglin J, Edelman ER. Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J Am Coll Cardiol. 2005 Jun 21;45(12):1939-45. PubMed PMID: 15963390. Epub 2005/06/21. eng.
Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunology letters. 2003 Jan 22;85(2):85-95. PubMed PMID: 12527213. Epub 2003/01/16. eng.
Imler JL, Hoffmann JA. Toll and Toll-like proteins: an ancient family of receptors signaling infection. Reviews in immunogenetics. 2000;2(3):294-304. PubMed PMID: 11256741. Epub 2001/03/21. eng.
Akira S. Mammalian Toll-like receptors. Current opinion in immunology. 2003 Feb;15(1):5-11. PubMed PMID: 12495726. Epub 2002/12/24. eng.
Wick G, Knoflach M, Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annual review of immunology. 2004;22:361-403. PubMed PMID: 15032582. Epub 2004/03/23. eng.
Heine H, Lien E. Toll-like receptors and their function in innate and adaptive immunity. International archives of allergy and immunology. 2003 Mar;130(3):180-92. PubMed PMID: 12660422. Epub 2003/03/28. eng.
Palazzo M, Gariboldi S, Zanobbio L, Dusio GF, Selleri S, Bedoni M, et al. Cross-talk among Toll-like receptors and their ligands. International immunology. 2008 May;20(5):709-18. PubMed PMID: 18397908. Epub 2008/04/10. eng.
Versteeg D, Hoefer IE, Schoneveld AH, de Kleijn DP, Busser E, Strijder C, et al. Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve. Heart. 2008 Jun;94(6):770-6. PubMed PMID: 17686802. Epub 2007/08/10. eng.
Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell. 2001 Feb 23;104(4):503-16. PubMed PMID: 11239408. Epub 2001/03/10. eng.
Jiang D, Liang J, Li Y, Noble PW. The role of Toll-like receptors in non-infectious lung injury. Cell research. 2006 Aug;16(8):693-701. PubMed PMID: 16894359. Epub 2006/08/09. eng.
Villar J, Cabrera NE, Casula M, Flores C, Valladares F, Diaz-Flores L, et al. Mechanical ventilation modulates TLR4 and IRAK-3 in a non-infectious, ventilator-induced lung injury model. Respiratory research. 2010;11:27. PubMed PMID: 20199666. Pubmed Central PMCID: PMC2841148. Epub 2010/03/05. eng.
Kakio T, Matsumori A, Ohashi N, Yamada T, Nobuhara M, Saito T, et al. The effect of hydrocortisone on reducing rates of restenosis and target lesion revascularization after coronary stenting less than 3 mm in stent diameter. Internal medicine (Tokyo, Japan). 2003 Nov;42(11):1084-9. PubMed PMID: 14686746. Epub 2003/12/23. eng.
Sriramula S, Cardinale JP, Lazartigues E, Francis J. ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc Res. 2011 Dec 1;92(3):401-8. PubMed PMID: 21952934. Pubmed Central PMCID: PMC3286198. Epub 2011/09/29. eng.
Bagheri B, Sohrabi B, Movassaghpour AA, Mashayekhi S, Garjani A, Shokri M, et al. Hydrocortisone reduces Toll-like receptor 4 expression on peripheral CD14+ monocytes in patients undergoing percutaneous coronary intervention. Iranian biomedical journal. 2014;18(2):76-81. PubMed PMID: 24518547. Pubmed Central PMCID: PMC3933915. Epub 2014/02/13. eng.
Moutzouri E, Tellis CC, Rousouli K, Liberopoulos EN, Milionis HJ, Elisaf MS, et al. Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients. Atherosclerosis. 2012 Dec;225(2):381-7. PubMed PMID: 23062767. Epub 2012/10/16. eng.
Hilgendorff A, Muth H, Parviz B, Staubitz A, Haberbosch W, Tillmanns H, et al. Statins differ in their ability to block NF-kappaB activation in human blood monocytes. International journal of clinical pharmacology and therapeutics. 2003 Sep;41(9):397-401. PubMed PMID: 14518599. Epub 2003/10/02. eng.
Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arteriosclerosis, thrombosis, and vascular biology. 2001 Nov;21(11):1712-9. PubMed PMID: 11701455. Epub 2001/11/10. eng.
Shimamoto A, Chong AJ, Yada M, Shomura S, Takayama H, Fleisig AJ, et al. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation. 2006 Jul 4;114(1 Suppl):I270-4. PubMed PMID: 16820585. Epub 2006/07/06. eng.
- Abstract Viewed: 324 times
- PDF Downloaded: 227 times